Prexton Therapeutics

Manufacturing · Switzerland · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Chemin Des Aulx 14, Plan-les-Ouates, Gen...

Phone Number

+41 225522292

Revenue

$6.1 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Prexton Therapeutics

Prexton Therapeutics is a biopharmaceutical company, founded in 2012 by Francois Conquet and Merck Ventures. It is part of a Merck Ventures entrepreneurial partnership program, which supports the creation of spin-offs from Merck. Prexton Therapeutics applies a new scientific approach that fully integrates molecular, behavioral and chemistry technologies to address Parkinson's disease and other brain disorders. Prexton Therapeutics uses its powerful discovery platform to target specific novel compounds focused on the treatment of Parkinson's disease. Prexton Therapeutics is based in Geneva (Switzerland) and in Amsterdam (The Netherlands).Explore more
Prexton Therapeutics's Social MediaPopular SearchesPrexton TherapeuticsPrexton Therapeutics SAPrexton Therapeutics BVPrextontherapeuticsPrextontherapeutics.comSIC Code 28,283NAICS Code 32,325Show more

Is Prexton Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Prexton Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Prexton Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Prexton Therapeutics.

Prexton Therapeutics financials insights

Gather financial insights about Prexton Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2015

Series A

$10M

2017

Series B

$31.2M

See All Prexton Therapeutics's Financials Insights

Prexton Therapeutics Tech Stack

A closer look at the technologies used by Prexton Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Prexton Therapeutics

What is Prexton Therapeutics's official website?
Prexton Therapeutics's official website is www.prextontherapeutics.com
What is Prexton Therapeutics's Revenue?
Prexton Therapeutics's revenue is $6.1 Million
What is Prexton Therapeutics's SIC code?
Prexton Therapeutics's SIC: 28,283
What is Prexton Therapeutics's NAICS code?
Prexton Therapeutics's NAICS: 32,325
How many employees does Prexton Therapeutics have?
Prexton Therapeutics has 11-50 employees
What industry does Prexton Therapeutics belong to?
Prexton Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What technology does Prexton Therapeutics use?
Some of the popular technologies that Prexton Therapeutics uses are: YouTube, Sectigo, The USERTRUST Network, Infomaniak Mail Hosting
How do I contact Prexton Therapeutics?
Prexton Therapeutics contact info: Phone number: +41 225522292 Website: www.prextontherapeutics.com
What does Prexton Therapeutics do?

Prexton Therapeutics is a biopharmaceutical company, founded in 2012 by Francois Conquet and Merck Ventures. It is part of a Merck Ventures entrepreneurial partnership program, which supports the creation of spin-offs from Merck. Prexton Therapeutics applies a new scientific approach that fully integrates molecular, behavioral and chemistry technol... ogies to address Parkinson's disease and other brain disorders. Prexton Therapeutics uses its powerful discovery platform to target specific novel compounds focused on the treatment of Parkinson's disease. Prexton Therapeutics is based in Geneva (Switzerland) and in Amsterdam (The Netherlands).Read More

What are Prexton Therapeutics social media links?
Prexton Therapeutics Linkedin page
Who invested in Prexton Therapeutics?
Prexton Therapeutics has 8 investors including Forbion, MS Ventures, Ysios Capital and Sunstone Capital.
Is Prexton Therapeutics a public company?
Prexton Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Prexton Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.